These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
719 related articles for article (PubMed ID: 23880169)
1. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France. Diene SM; L'homme T; Bellulo S; Stremler N; Dubus JC; Mely L; Leroy S; Degand N; Rolain JM Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169 [TBL] [Abstract][Full Text] [Related]
2. Inactivation of the oprD porin gene by a novel insertion sequence ISPa195 associated with large deletion in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate. Bocharova Y; Savinova T; Shagin DA; Shelenkov AA; Mayanskiy NA; Chebotar IV J Glob Antimicrob Resist; 2019 Jun; 17():309-311. PubMed ID: 30684654 [TBL] [Abstract][Full Text] [Related]
3. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea. Lee JY; Ko KS Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564 [TBL] [Abstract][Full Text] [Related]
4. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates. El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762 [TBL] [Abstract][Full Text] [Related]
5. Phenotypic and genetic resistance traits of Pseudomonas aeruginosa strains infecting cystic fibrosis patients: A French cohort study. Courtois N; Caspar Y; Maurin M Int J Antimicrob Agents; 2018 Sep; 52(3):358-364. PubMed ID: 29775685 [TBL] [Abstract][Full Text] [Related]
6. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study. Llanes C; Pourcel C; Richardot C; Plésiat P; Fichant G; Cavallo JD; Mérens A; J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014 [TBL] [Abstract][Full Text] [Related]
7. Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa. Fournier D; Richardot C; Müller E; Robert-Nicoud M; Llanes C; Plésiat P; Jeannot K J Antimicrob Chemother; 2013 Aug; 68(8):1772-80. PubMed ID: 23587654 [TBL] [Abstract][Full Text] [Related]
8. Emergence of Carbapenem-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Clinical Isolates Collected from Some Libyan Hospitals. Mathlouthi N; Areig Z; Al Bayssari C; Bakour S; Ali El Salabi A; Ben Gwierif S; Zorgani AA; Ben Slama K; Chouchani C; Rolain JM Microb Drug Resist; 2015 Jun; 21(3):335-41. PubMed ID: 25587875 [TBL] [Abstract][Full Text] [Related]
9. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa clinical strains isolated from western Algeria between 2009 and 2012. Sefraoui I; Berrazeg M; Drissi M; Rolain JM Microb Drug Resist; 2014 Apr; 20(2):156-61. PubMed ID: 24320688 [TBL] [Abstract][Full Text] [Related]
11. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals. Kim CH; Kang HY; Kim BR; Jeon H; Lee YC; Lee SH; Lee JC J Microbiol; 2016 Jan; 54(1):44-49. PubMed ID: 26727901 [TBL] [Abstract][Full Text] [Related]
12. Insertion sequence ISRP10 inactivation of the oprD gene in imipenem-resistant Pseudomonas aeruginosa clinical isolates. Sun Q; Ba Z; Wu G; Wang W; Lin S; Yang H Int J Antimicrob Agents; 2016 May; 47(5):375-9. PubMed ID: 27061775 [TBL] [Abstract][Full Text] [Related]
13. Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates. Naenna P; Noisumdaeng P; Pongpech P; Tribuddharat C Southeast Asian J Trop Med Public Health; 2010 May; 41(3):614-24. PubMed ID: 20578550 [TBL] [Abstract][Full Text] [Related]
14. Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallo-beta-lactamases, porin OprD and integrons. Rojo-Bezares B; Estepa V; Cebollada R; de Toro M; Somalo S; Seral C; Castillo FJ; Torres C; Sáenz Y Int J Med Microbiol; 2014 May; 304(3-4):405-14. PubMed ID: 24594145 [TBL] [Abstract][Full Text] [Related]
15. Reduced production of OprM may promote oprD mutations and lead to imipenem resistance in Pseudomonas aeruginosa carrying an oprD-group 1A allele. Shu JC; Su LH; Chiu CH; Kuo AJ; Liu TP; Lee MH; Su IN; Wu TL Microb Drug Resist; 2015 Apr; 21(2):149-57. PubMed ID: 25386722 [TBL] [Abstract][Full Text] [Related]
16. A novel insertion sequence, ISPA26, in oprD of Pseudomonas aeruginosa is associated with carbapenem resistance. Evans JC; Segal H Antimicrob Agents Chemother; 2007 Oct; 51(10):3776-7. PubMed ID: 17682099 [No Abstract] [Full Text] [Related]
17. Role of outer membrane protein OprD and penicillin-binding proteins in resistance of Pseudomonas aeruginosa to imipenem and meropenem. Farra A; Islam S; Strålfors A; Sörberg M; Wretlind B Int J Antimicrob Agents; 2008 May; 31(5):427-33. PubMed ID: 18375104 [TBL] [Abstract][Full Text] [Related]
18. Classification of OprD sequence and correlation with antimicrobial activity of carbapenem agents in Pseudomonas aeruginosa clinical isolates collected in Japan. Sanbongi Y; Shimizu A; Suzuki T; Nagaso H; Ida T; Maebashi K; Gotoh N Microbiol Immunol; 2009 Jul; 53(7):361-7. PubMed ID: 19563394 [TBL] [Abstract][Full Text] [Related]
19. Carbapenem resistance in cystic fibrosis strains of Pseudomonas aeruginosa as a result of amino acid substitutions in porin OprD. Richardot C; Plésiat P; Fournier D; Monlezun L; Broutin I; Llanes C Int J Antimicrob Agents; 2015 May; 45(5):529-32. PubMed ID: 25735764 [TBL] [Abstract][Full Text] [Related]